Adelana Tade

Experienced Senior CRA III who has performed monitoring and site management activities in several therapeutic areas including Oncology with Indications in Lung Cancer, Multiple Myeloma, Acute Myeloid Leukemia and Solid Tumor, as well as Neurology, with indications in Schizophrenia, Huntington Disease, Dementia and Parkinson Disease for phase I-III clinical research projects. I have also participated in a Long-Time -Follow-Up study (post marketing phase) where I accessed the progress of clinical projects at assigned investigative/physician sites, ensuring clinical projects are conducted, recorded, and reported in accordance with the protocol, company and sponsors standard operating procedures (SOPs) & ICH-GCP. Therapeutic Summary Experienced Senior CRA III who has performed monitoring and site management activities in several therapeutic areas including Oncology with Indications in Lung Cancer, Multiple Myeloma, Acute Myeloid Leukemia and Solid Tumor, as well as Neurology, with indications in Schizophrenia. Oncology (5 years): Lung 5 Phase III, Multiple Myeloma 3 Phase I/II, Lymphoma 3 Phase I/III, Multiple solid tumors dose finding and Escalation Phase II. Neurology/CNS (3 Years): Schizophrenia Phase I/II, Huntington Disease Phase I/II, Parkinson Disease phase III Infectious Diseases (3 Years) Flu Phase III. Rare Disease (2 Years) Cystic Fibrosis Phase III. Medical devices (3years): Heart value, CGDM, IVD Cardiovascular (2.5yrs): Hypertension and Myocardial Infraction.

Equipped with strong problem-solving abilities, willingness to learn, and excellent communication skills. Poised to contribute to team success and achieve positive results. Ready to tackle new challenges and advance organizational objectives with dedication and enthusiasm.

• Achieved sponsors recognition in timely query resolution by collaborating withsite in data lock deadlines.
• Collaborated with team 5 senior CRAs to act as SWAT team for other studies through my ability to multitask.